Annual Total Liabilities
$446.82 M
+$25.28 M+6.00%
31 December 2023
Summary:
ANI Pharmaceuticals annual total liabilities is currently $446.82 million, with the most recent change of +$25.28 million (+6.00%) on 31 December 2023. During the last 3 years, it has risen by +$181.33 million (+68.30%). ANIP annual total liabilities is now at all-time high.ANIP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$856.58 M
+$416.44 M+94.61%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly total liabilities is currently $856.58 million, with the most recent change of +$416.44 million (+94.61%) on 30 September 2024. Over the past year, it has increased by +$421.38 million (+96.82%). ANIP quarterly total liabilities is now at all-time high.ANIP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.0% | +96.8% |
| 3 y3 years | +68.3% | +207.0% |
| 5 y5 years | +91.5% | +251.6% |
ANIP Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +68.3% | at high | +207.0% |
| 5 y | 5 years | at high | +91.5% | at high | +251.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ANI Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $856.58 M(+94.6%) |
| June 2024 | - | $440.14 M(+0.6%) |
| Mar 2024 | - | $437.71 M(-2.0%) |
| Dec 2023 | $446.82 M(+6.0%) | $446.82 M(+2.7%) |
| Sept 2023 | - | $435.20 M(+2.4%) |
| June 2023 | - | $424.87 M(-0.2%) |
| Mar 2023 | - | $425.74 M(+1.0%) |
| Dec 2022 | $421.55 M(+2.1%) | $421.55 M(+4.7%) |
| Sept 2022 | - | $402.44 M(-2.9%) |
| June 2022 | - | $414.38 M(+3.9%) |
| Mar 2022 | - | $398.75 M(-3.4%) |
| Dec 2021 | $412.86 M(+55.5%) | $412.86 M(+48.0%) |
| Sept 2021 | - | $279.05 M(-3.2%) |
| June 2021 | - | $288.24 M(+10.8%) |
| Mar 2021 | - | $260.13 M(-2.0%) |
| Dec 2020 | $265.49 M(+8.8%) | $265.49 M(-0.7%) |
| Sept 2020 | - | $267.48 M(-2.4%) |
| June 2020 | - | $274.05 M(-2.5%) |
| Mar 2020 | - | $281.06 M(+15.2%) |
| Dec 2019 | $244.00 M(+4.6%) | $244.00 M(+0.1%) |
| Sept 2019 | - | $243.65 M(+1.8%) |
| June 2019 | - | $239.25 M(+1.9%) |
| Mar 2019 | - | $234.68 M(+0.6%) |
| Dec 2018 | $233.34 M(-1.7%) | $233.34 M(-5.5%) |
| Sept 2018 | - | $246.98 M(+3.3%) |
| June 2018 | - | $239.07 M(+0.3%) |
| Mar 2018 | - | $238.38 M(+0.4%) |
| Dec 2017 | $237.38 M(+54.9%) | $237.38 M(+26.5%) |
| Sept 2017 | - | $187.67 M(+2.7%) |
| June 2017 | - | $182.67 M(-1.2%) |
| Mar 2017 | - | $184.93 M(+20.7%) |
| Dec 2016 | $153.22 M(+22.4%) | $153.22 M(+1.8%) |
| Sept 2016 | - | $150.55 M(+4.4%) |
| June 2016 | - | $144.22 M(+9.8%) |
| Mar 2016 | - | $131.41 M(+5.0%) |
| Dec 2015 | $125.18 M(+4.5%) | $125.18 M(-1.7%) |
| Sept 2015 | - | $127.38 M(+5.6%) |
| June 2015 | - | $120.62 M(-0.5%) |
| Mar 2015 | - | $121.25 M(+1.2%) |
| Dec 2014 | $119.77 M(+3285.3%) | $119.77 M(+1370.5%) |
| Sept 2014 | - | $8.14 M(+112.8%) |
| June 2014 | - | $3.83 M(-16.1%) |
| Mar 2014 | - | $4.56 M(+28.9%) |
| Dec 2013 | $3.54 M(-66.6%) | $3.54 M(-46.4%) |
| Sept 2013 | - | $6.60 M(+7.0%) |
| June 2013 | - | $6.16 M(-33.9%) |
| Mar 2013 | - | $9.33 M(-12.0%) |
| Dec 2012 | $10.59 M | $10.59 M(-3.0%) |
| Sept 2012 | - | $10.92 M(-33.3%) |
| June 2012 | - | $16.37 M(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $16.58 M(-32.5%) |
| Dec 2011 | $24.56 M(-4.1%) | $24.56 M(-20.1%) |
| Sept 2011 | - | $30.74 M(-1.6%) |
| June 2011 | - | $31.23 M(+1.8%) |
| Mar 2011 | - | $30.67 M(+19.7%) |
| Dec 2010 | $25.62 M(+24.3%) | $25.62 M(+0.6%) |
| Sept 2010 | - | $25.46 M(+1.2%) |
| June 2010 | - | $25.16 M(+3.5%) |
| Mar 2010 | - | $24.31 M(+18.0%) |
| Dec 2009 | $20.61 M(+434.8%) | $20.61 M(+331.4%) |
| Sept 2009 | - | $4.78 M(+28.5%) |
| June 2009 | - | $3.72 M(+19.7%) |
| Mar 2009 | - | $3.10 M(-19.4%) |
| Dec 2008 | $3.85 M(+154.2%) | $3.85 M(-15.7%) |
| Sept 2008 | - | $4.57 M(+26.2%) |
| June 2008 | - | $3.62 M(+23.7%) |
| Mar 2008 | - | $2.93 M(+93.1%) |
| Dec 2007 | $1.52 M(-64.7%) | $1.52 M(-32.2%) |
| Sept 2007 | - | $2.23 M(-14.4%) |
| June 2007 | - | $2.61 M(+7.4%) |
| Mar 2007 | - | $2.43 M(-43.5%) |
| Dec 2006 | $4.30 M(+56.0%) | $4.30 M(+152.0%) |
| Sept 2006 | - | $1.71 M(-26.6%) |
| June 2006 | - | $2.33 M(-16.7%) |
| Mar 2006 | - | $2.79 M(+1.3%) |
| Dec 2005 | $2.76 M(+44.5%) | $2.76 M(+71.5%) |
| Sept 2005 | - | $1.61 M(+3.6%) |
| June 2005 | - | $1.55 M(-14.4%) |
| Mar 2005 | - | $1.81 M(-5.0%) |
| Dec 2004 | $1.91 M(+116.4%) | $1.91 M(+42.7%) |
| Sept 2004 | - | $1.34 M(+13.6%) |
| June 2004 | - | $1.18 M(+2.6%) |
| Mar 2004 | - | $1.15 M(+30.1%) |
| Dec 2003 | $881.20 K(-29.9%) | $881.20 K(+25.9%) |
| Sept 2003 | - | $700.10 K(-2.8%) |
| June 2003 | - | $720.60 K(+29.9%) |
| Mar 2003 | - | $554.90 K(-55.8%) |
| Dec 2002 | $1.26 M(+35.4%) | $1.26 M(+81.3%) |
| Sept 2002 | - | $692.80 K(-5.8%) |
| June 2002 | - | $735.70 K(+8.5%) |
| Mar 2002 | - | $678.20 K(-26.9%) |
| Dec 2001 | $927.80 K(-1.4%) | $927.80 K(-9.8%) |
| Sept 2001 | - | $1.03 M(+9.4%) |
| June 2001 | - | $940.70 K(+18.4%) |
| Mar 2001 | - | $794.50 K(-15.6%) |
| Dec 2000 | $941.30 K(+186.0%) | $941.30 K(+35.0%) |
| Sept 2000 | - | $697.30 K(+182.1%) |
| June 2000 | - | $247.20 K(-13.7%) |
| Mar 2000 | - | $286.30 K |
| Dec 1999 | $329.10 K(-59.8%) | - |
| Dec 1998 | $817.90 K | - |
FAQ
- What is ANI Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual total liabilities year-on-year change?
- What is ANI Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly total liabilities year-on-year change?
What is ANI Pharmaceuticals annual total liabilities?
The current annual total liabilities of ANIP is $446.82 M
What is the all time high annual total liabilities for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual total liabilities is $446.82 M
What is ANI Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ANIP annual total liabilities has changed by +$25.28 M (+6.00%)
What is ANI Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ANIP is $856.58 M
What is the all time high quarterly total liabilities for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly total liabilities is $856.58 M
What is ANI Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ANIP quarterly total liabilities has changed by +$421.38 M (+96.82%)